Medizinische Fakultät

Chromatic visual evoked potentials: A review of physiology, methods and clinical applications (2024) Marmoy OR, Tekavčič Pompe M, Kremers J Journal article, Review article A multimodal aftercare intervention improves the outcome after kidney transplantation – results of the KTx360° aftercare program using claims data (2024) Pape L, DeZwaan M, Nöhre M, Klewitz F, Kyaw Tha Tun E, Prüfe J, Schiffer L, et al. Journal article Impact of intelligent virtual and AI-based automated collimation functionalities on the efficiency of radiographic acquisitions (2024) Rasche A, Brader P, Borggrefe J, Seuß H, Carr Z, Hebecker A, ten Cate G Journal article Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study (2024) Lüftner D, Schuetz F, Schneeweiss A, Hartkopf A, Bloch W, Decker T, Uleer C, et al. Journal article Corrigendum to “RIP1-RIP3-DRP1 pathway regulates NLRP3 inflammasome activation following subarachnoid hemorrhage”. Experimental Neurology. 2017 Sep: 295:116–124. (Experimental Neurology (2017) 295 (116–124), (S0014488617301425), (10.1016/j.expneurol.2017.06.003)) (2024) Zhou K, Shi L, ZhenWang , Zhou J, Manaenko A, Reis C, Chen S, Zhang J Journal article, Erratum Case-tailored indicated extracapsular dissection versus “one-size-fits-all” nerve dissection: Has the bet been won? (2024) Mantsopoulos K, Gehrking M, Thimsen V, Sievert M, Müller SK, Rupp R, Balk M, et al. Journal article Correlates of perceived shared decision making with parents of children with special healthcare needs: Findings from the PART-CHILD study (2024) Görig T, Eichinger M, Georg S, Hoffmann D, Philippi H, König J, Urschitz MS, De Bock F Journal article Suppressing Pro-Apoptotic Proteins by siRNA in Corneal Endothelial Cells Protects against Cell Death (2024) Staehlke S, Mahajan S, Thieme D, Trosan P, Fuchsluger TA Journal article 177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study (2024) Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel ME, Kunz PL, Chasen B, et al. Journal article Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study (2024) Taylor PC, Schett G, Huizinga TW, Wang Q, Ibrahim F, Zhou B, Liva SG, et al. Journal article